- GlobeNewswire•5 hours agoSanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility - The large-scale facility, to be built in Visp, Switzerland, will be established through a ...
- Motley Fool•2 days ago
It only took four drugs to do it.
- Motley Fool•4 days ago
Carl Icahn has reportedly bought shares in this big-cap biopharma, but Bristol-Myers Squibb might be too big and costly to win an acquirer.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||80.29 - 81.00|
|52 Week Range||62.50 - 82.45|
|PE Ratio (TTM)||21.94|
|Dividend & Yield||3.35 (3.93%)|
|1y Target Est||N/A|